Comprehensive analysis of ESR1-related ceRNA axis as a novel prognostic biomarker in hepatocellular carcinoma

H Luo, Q Jiang, Y Luo, M Yang, Y Yu, C Yu, X Wang - Epigenomics, 2022 - Future Medicine
Aims: To further understand, detect and treat hepatocellular carcinoma (HCC), it is urgent to
conduct more in-depth research on the mechanism of sex-associated differences. Materials …

Comprehensive analysis of ESR1-related ceRNA axis as a novel prognostic biomarker in hepatocellular carcinoma.

H Luo, Q Jiang, Y Luo, M Yang, Y Yu, C Yu, X Wang - Epigenomics, 2023 - europepmc.org
Aims: To further understand, detect and treat hepatocellular carcinoma (HCC), it is urgent to
conduct more in-depth research on the mechanism of sex-associated differences. Materials …

Comprehensive analysis of ESR1-related ceRNA axis as a novel prognostic biomarker in hepatocellular carcinoma

H Luo, Q Jiang, Y Luo, M Yang, Y Yu, C Yu… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Aims: To further understand, detect and treat hepatocellular carcinoma (HCC), it is urgent to
conduct more in-depth research on the mechanism of sex-associated differences. Materials …

Comprehensive analysis of ESR1-related ceRNA axis as a novel prognostic biomarker in hepatocellular carcinoma

H Luo, Q Jiang, Y Luo, M Yang, Y Yu, C Yu, X Wang - Epigenomics, 2022 - Taylor & Francis
Aims: To further understand, detect and treat hepatocellular carcinoma (HCC), it is urgent to
conduct more in-depth research on the mechanism of sex-associated differences. Materials …